I have looked at this share on and off and finally took the plunge because I saw with my own eyes what at least one of the therapies can do. The one I refer to was referenced in the BBC programme and showed a patient after the stem cell technology had been used. What a difference. There is a link in the posts further down if you havent seen it. Im sure someone here will have it.
Good morning Ezik..info c/o Vach iii site. Hope this helps....
Keep the faith people (excerpt from July's interims):
· CTX cell therapy candidate for motor disability as a result of stroke: - Phase II clinical trial - recruitment completed, data expected in Q4 2016 - Pivotal Phase II/III clinical trial planned to commence in H1 2017
· CTX cell therapy candidate for critical limb ischaemia: - Phase I clinical trial ongoing - data expected in H2 2016 - Phase II clinical… Read More
I bought £3000 of these shares on the basis that I saw Woodford has a large holding in them. Can someone enlighten me if the hopes of a windfall on this share rests entirely with a medical breakthrough in one of its research projects?
Thanks Dibs. Your post is much appreciated. I guess I will never get the hang of predicting sp movement / trending so any learned advice is appreciated. Thanks once again and here's hoping for a decent correction on positive news. Best wishes. Fred
....it appears to me that whenever I post a prediction that's a positive for the sp it invariably gets shifted by the mm's in the opposite direction. I'm really not paranoid about this; but it invariably happens. Thing is the actual trading doesn't appear to change that much. Anyway I'm not put off, just think, its so funny. Happens today I managed to top up a tad on the dip, so well done mm's. Keep up the good work.
Datafeed and UK data supplied by NBTrader and Digital Look.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.